Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

cyclin-dependent kinase-like 1 (CDC2-related kinase), Mouse, Clone: 1F12, Abnova™

Mouse monoclonal antibody raised against a partial recombinant CDKL1.

Supplier:  Abnova Corporation H00008814M03

Catalog No. 89-001-101


Only null left
Add to Cart

Description

Description

This gene product is a member of a large family of CDC2-related serine/threonine protein kinases. It accumulates primarily in the nucleus. Alternative splice variants encoding different protein isoforms have been described, but their full-length nature has not been determined. [provided by RefSeq

Sequence: YPALGLLKGCLHMDPTQRLTCEQLLHHPYFENIREIEDLAKEHNKPTRKTLRKSRKHHCFTETSKLQYLPQLTGSSILPALDNKKYYCDTKKLNYRFPNI
Specifications

Specifications

cyclin-dependent kinase-like 1 (CDC2-related kinase)
Monoclonal
Unconjugated
PBS with no preservative; pH 7.4
NM_004196
CDKL1
CDKL1 (NP_004187, 259 a.a. ∼ 358 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
100 μg
Cell Cycle
Primary
Human
Antibody
ELISA, Immunofluorescence, Immunohistochemistry (PFA fixed), Western Blot
1F12
Mouse monoclonal antibody raised against a partial recombinant CDKL1.
CDKL1
KKIALRE/p42
Mouse
Affinity Purified
RUO
Yes
8814
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
IgG2a κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.